Carl L. Gordon SEC insider filings

Historical public-company ownership and transaction filings, with links to the original SEC records.

What the SEC filings show

Carl L. Gordon is named as a reporting owner in 15 source-backed SEC filings in this collection, associated with 6 public-company issuers. The most recent included filing was submitted Nov 5, 2026.

Filings may report stock transactions or holdings at a particular time. They do not establish the person's current share balance, portfolio value, total net worth, or whether a transaction was an open-market purchase or sale.

Source filings
15
Issuers represented
6
Filings with transactions
10
Filings with holdings
5

Recent SEC source documents

A selection of the latest 3 relevant source filings. Counts describe reported rows in the filing, not verified trades, economic proceeds, or personal profits. Older filings and amendments may contain different information.

FiledIssuerReported relationshipRowsOriginal SEC filing
Nov 5, 2026Electra Therapeutics, Inc.Director, 10% owner10 transaction / 0 holdingForm 4 · 0000947871-26-000986
Sep 30, 2026ADARx Pharmaceuticals, Inc.Director, 10% owner19 transaction / 0 holdingForm 4 · 0000947871-26-000911
Sep 24, 2026ADARx Pharmaceuticals, Inc.Director, 10% owner0 transaction / 8 holdingForm 3 · 0001282930-26-000014

How to interpret this evidence

SEC Forms 3, 4 and 5 disclose certain ownership and transaction observations. Reporting dates, beneficial ownership, derivative instruments, indirect positions and amendments can affect interpretation. Figures here are counts of filing records, not independent valuations. Exact total net worth is not publicly known from this filing record.

Browse this reporting owner's SEC filing history

Explore people and ownership research